SB Investment Advisers (UK) Ltd's Form 4 filing
Vir Biotechnology, Inc. (VIR) · filed Oct 28, 2025
- Accession no.
- 0001493152-25-019892
- Filed
- Oct 28, 2025, 4:30 PM ET
- Trade date
- Oct 24-27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $679.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| SB Investment Advisers (UK) LtdCIK 0001731509 | 10% Owner |
| Softbank Vision Fund (Aiv M1) L.P.CIK 0001755143 | 10% Owner |
| SVF Endurance (Cayman) LtdCIK 0001782338 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2025 | Common Stock | SSaleDisposed | −46,696 | $5.96 | −$278,284.81 | 14,664,939 | Indirect | |
| Oct 27, 2025 | Common Stock | SSaleDisposed | −66,403 | $6.05 | −$401,585.42 | 14,598,536 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.